Dean L Schorno
CIK 1509688 · EVP & Chief Financial Officer · last filed 2026-06-03
Dean L Schorno is an EVP & Chief Financial Officer who has filed 61 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing, for RIGL, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$1.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.55M
2
61
-$1.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | EVP & Chief Financial Officer | 77,537 | $32.85 | $2.55M | $2.6K | 28 | 2026-06-03 |
| GENOMIC HEALTH INC (GHDX) Delisted | CFO | 29,963 | — | — | -$1.82M | 33 | 2014-02-19 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | RIGL | Mixed | +2,453 | $22.4K | EDGAR |
| 2026-02-19 | RIGL | Grant (A) | +20,636 | $0 | EDGAR |
| 2026-02-12 | RIGL | Tax (F) | −3,546 | -$122.8K | EDGAR |
| 2026-02-04 | RIGL | Tax (F) | −5,488 | -$197.6K | EDGAR |
| 2025-12-29 | RIGL | Exer (M) | +6,500 | $139.8K | EDGAR |
| 2025-09-17 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2025-03-19 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | RIGL | Sell (S) | −3,770 | -$80.6K | EDGAR |
| 2025-01-31 | RIGL | Grant (A) | +19,717 | $0 | EDGAR |
| 2024-11-26 | RIGL | Grant (A) | — | $0 | EDGAR |